| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Murdoch Institute (Drs. Kirby, Crawford, Cleary, Dahl, and Thorburn) Royal Children’s Hospital, Melbourne, Australia; the Victorian State Neuropathology Service (Dr. Dennett), Department of Pathology, University of Melbourne, Australia; and the Willink Biochemical Genetics Unit (Dr. Cleary), Royal Manchester Children’s Hospital, Manchester, UK.
Address correspondence and reprint requests to Dr. David Thorburn, The Murdoch Institute, Royal Children’s Hospital, Flemington Road, Parkville, VIC 3052, Australia.
OBJECTIVE: To define the spectrum of clinical and biochemical features in 51 children with isolated complex I deficiency.
BACKGROUND: Mitochondrial respiratory chain defects are one of the most commonly diagnosed inborn errors of metabolism. Until recently there have been technical problems with the diagnosis of respiratory chain complex I defects, and there is a lack of information about this underreported cause of respiratory chain dysfunction.
METHODS: A retrospective review of clinical features and laboratory findings was undertaken in all diagnosed patients who had samples referred over a 22-year period.
RESULTS: Presentations were heterogeneous, ranging from severe multisystem disease with neonatal death to isolated myopathy. Classic indicators of respiratory chain disease were not present in 16 of 42 patients in whom blood lactate levels were normal on at least one occasion, and in 23 of 37 patients in whom muscle morphology was normal or nonspecific. Ragged red fibers were present in only five patients. Tissue specificity was observed in 19 of 41 patients in whom multiple tissues were examined, thus the diagnosis may be missed if the affected tissue is not analyzed. Nine patients had only skin fibroblasts available, the diagnosis being based on enzyme assay and functional tests. Modes of inheritance include autosomal recessive (suggested in five consanguineous families), maternal (mitochondrial DNA point mutations in eight patients), and possibly X-linked (slight male predominance of 30:21). Recurrence risk was estimated as 20 to 25%.
CONCLUSION: Heterogeneous clinical features, tissue specificity, and absence of lactic acidosis or abnormal mitochondrial morphology in many patients have resulted in underdiagnosis of respiratory chain complex I deficiency.
This article has been cited by other articles:
|
|
 |
|
  K. Gibson, J. L. Halliday, D. M. Kirby, J. Yaplito-Lee, D. R. Thorburn, and A. Boneh Mitochondrial Oxidative Phosphorylation Disorders Presenting in Neonates: Clinical Manifestations and Enzymatic and Molecular Diagnoses Pediatrics, November 1, 2008; 122(5): 1003 - 1008. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Wiltshire, G. Davidzon, S. DiMauro, H. O. Akman, L. Sadleir, L. Haas, J. Zuccollo, A. McEwen, and D. R. Thorburn Juvenile Alpers Disease Arch Neurol, January 1, 2008; 65(1): 121 - 124. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Iuso, S. Scacco, C. Piccoli, F. Bellomo, V. Petruzzella, R. Trentadue, M. Minuto, M. Ripoli, N. Capitanio, M. Zeviani, et al. Dysfunctions of Cellular Oxidative Metabolism in Patients with Mutations in the NDUFS1 and NDUFS4 Genes of Complex I J. Biol. Chem., April 14, 2006; 281(15): 10374 - 10380. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. M. Hutchison, D. Thyagarajan, J. Poulton, D. R. Marchington, D. M. Kirby, S. S. M. Manji, and H.-H. M. Dahl Clinical and Molecular Features of Encephalomyopathy Due to the A3302G Mutation in the Mitochondrial tRNALeu(UUR) Gene Arch Neurol, December 1, 2005; 62(12): 1920 - 1923. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Garcia-Cazorla, P. De Lonlay, M.C. Nassogne, P. Rustin, G. Touati, and J.M. Saudubray Long-term Follow-up of Neonatal Mitochondrial Cytopathies: A Study of 57 Patients Pediatrics, November 1, 2005; 116(5): 1170 - 1177. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Mancuso, S. Ferraris, J. Pancrudo, A. Feigenbaum, J. Raiman, J. Christodoulou, D. R. Thorburn, and S. DiMauro New DGK Gene Mutations in the Hepatocerebral Form of Mitochondrial DNA Depletion Syndrome Arch Neurol, May 1, 2005; 62(5): 745 - 747. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D M Kirby, R McFarland, A Ohtake, C Dunning, M T Ryan, C Wilson, D Ketteridge, D M Turnbull, D R Thorburn, and R W Taylor Mutations of the mitochondrial ND1 gene as a cause of MELAS J. Med. Genet., October 1, 2004; 41(10): 784 - 789. [Full Text] [PDF]
|
|
|
|
|
|
F. Scaglia, J. A. Towbin, W. J. Craigen, J. W. Belmont, E. O. Smith, S. R. Neish, S. M. Ware, J. V. Hunter, S. D. Fernbach, G. D. Vladutiu, et al. Clinical Spectrum, Morbidity, and Mortality in 113 Pediatric Patients With Mitochondrial Disease Pediatrics, October 1, 2004; 114(4): 925 - 931. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Skladal, C. Sudmeier, V. Konstantopoulou, S. Stockler-Ipsiroglu, B. Plecko-Startinig, G. Bernert, J. Zeman, and W. Sperl The Clinical Spectrum of Mitochondrial Disease in 75 Pediatric Patients Clinical Pediatrics, October 1, 2003; 42(8): 703 - 710. [Abstract] [PDF]
|
|
|
|
 |
|
 D. Skladal, J. Halliday, and D. R Thorburn Minimum birth prevalence of mitochondrial respiratory chain disorders in children Brain, August 1, 2003; 126(8): 1905 - 1912. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F.P. Bernier, A. Boneh, X. Dennett, C.W. Chow, M.A. Cleary, and D.R. Thorburn Diagnostic criteria for respiratory chain disorders in adults and children Neurology, November 12, 2002; 59(9): 1406 - 1411. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Shoubridge Nuclear genetic defects of oxidative phosphorylation Hum. Mol. Genet., October 1, 2001; 10(20): 2277 - 2284. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
